Shengquan Hu
- Pharmacology top 5%
- Cholinesterase and Neurodegenerative Diseases 12
- Berberine and alkaloids research 3
- Neurology top 5%
- Neuroinflammation and Neurodegeneration Mechanisms 10
- Neurological Disorders and Treatments 4
- Parkinson's Disease Mechanisms and Treatments 3
- Physiology top 10%
- Alzheimer's disease research and treatments 10
- Developmental Neuroscience top 10%
-
- Neuroscience and Neuropharmacology Research 11
-
- Nicotinic Acetylcholine Receptors Study 6
Shengquan Hu
40 papers receiving 996 citations
Peers
Comparison fields: 5 of 98
- Complementary and alternative medicine 169
- Pharmacology 310
- Neurology 136
- Physiology 307
- Developmental Neuroscience 48
Countries citing papers authored by Shengquan Hu
This map shows the geographic impact of Shengquan Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shengquan Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shengquan Hu more than expected).
Fields of papers citing papers by Shengquan Hu
This network shows the impact of papers produced by Shengquan Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shengquan Hu. The network helps show where Shengquan Hu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Shengquan Hu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 17 | |
| 2 | 2020 | 9 | |
| 3 | 2020 | 9 | |
| 4 | 2020 | 23 | |
| 5 | 2019 | 9 | |
| 6 | 2018 | 37 | |
| 7 | 2018 | 26 | |
| 8 | 2017 | 24 | |
| 9 | 2017 | 20 | |
| 10 | 2016 | 10 | |
| 11 | 2015 | 20 | |
| 12 | 2015 | 13 | |
| 13 | 2015 | 29 | |
| 14 | 2014 | 47 | |
| 15 | 2014 | 14 | |
| 16 | 2013 | 18 | |
| 17 | 2013 | 39 | |
| 18 | 2012 | 54 | |
| 19 | 2011 | 32 | |
| 20 | 2011 | 62 |
About Shengquan Hu
Shengquan Hu is a scholar working on Neurology, Pharmacology and Cellular and Molecular Neuroscience, having authored 40 papers that have together received 1.0k indexed citations. Recurring topics across this work include Cholinesterase and Neurodegenerative Diseases (12 papers), Neuroscience and Neuropharmacology Research (11 papers), Alzheimer's disease research and treatments (10 papers), Neuroinflammation and Neurodegeneration Mechanisms (10 papers), Nicotinic Acetylcholine Receptors Study (6 papers), Neurological Disorders and Treatments (4 papers), Berberine and alkaloids research (3 papers) and Parkinson's Disease Mechanisms and Treatments (3 papers). The work is most often cited by research in Complementary and alternative medicine (169 citations), Pharmacology (310 citations) and Neurology (136 citations). Shengquan Hu has collaborated with scholars based in Hong Kong, China and United States. Frequent co-authors include Yifan Han, Shinghung Mak, Wei Cui, Zaijun Zhang, Ren-Wen Han, Simon Ming‐Yuen Lee, Karl Wah Keung Tsim, Daping Xu, Huan Zhang and Yuan‐Ping Pang. Their work appears in journals such as CNS Neuroscience & Therapeutics, ACS Chemical Neuroscience, Frontiers in Pharmacology, Journal of Molecular Neuroscience and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.